3-G1F 2AB (500pmol/vial)>95.0%(HPLC)1vial

5-Amino-1-(3-methoxyphenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 250mg

Flacon à col large, 250 ml, GL 45, 6 pièce(s)

N-((4aR,7R,8R,8aS)-6,8-Dihydroxy-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-7-yl)acetamide, 95.0%, 250mg

2-(1-(tert-Butoxycarbonyl)azetidin-3-yl)acetic acid, 95.0%, 25g

1,4-Dichloro-2-fluoro-5-nitrobenzene, 100mg

2,4,6-Triphenyl-1,3,5,2,4,6-trioxatriborinane, 95.0%, 5g

(2E)-3-(furan-2-yl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

(3-Amino-2-methylphenyl)methanol, 97.0%, 25g

Iron (III) chloride hexahydrate, 99.0%, 100g

Ethyl 1,2,4-oxadiazole-3-carboxylate, 97%, 500mg

3-Bromo-5-iodobenzoic acid, 97.0%, 5g

5-(Benzyloxy)-2-chloropyrimidine, 95.0%, 5g